Inhibition of proinflammatory cytokines by SCH79797, a selective protease-activated receptor 1 antagonist, protects rat kidney against ischemia-reperfusion injury

Shock

Volumn 37, Issue 6, 2012, Pages 639-644

  El Eter, Eman Abdelazeem ^a   Aldrees, Abdulmajeed ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

inflammatory cytokines; P selectin; PAR1 receptors; Renal ischemia reperfusion injury; SCH79797

Indexed keywords

CHEMOATTRACTANT; CREATININE; CYTOKINE; PADGEM PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEINASE ACTIVATED RECEPTOR 1; RECEPTOR BLOCKING AGENT; SCH 79797; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HISTOPATHOLOGY; KIDNEY INJURY; MALE; NEPHRECTOMY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REPERFUSION INJURY;

ANIMALS; CHEMOKINE CXCL1; CREATININE; KIDNEY; MALE; NEUTROPHIL INFILTRATION; P-SELECTIN; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; PYRROLES; QUINAZOLINES; RATS; RATS, WISTAR; RECEPTOR, PAR-1; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861456104     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182507774     Document Type: Article

References (34)

1. Sharfuddin AA, Molitoris BA: Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol 4:189-200, 2011.
2. Heinzelmann M, Mercer-Jones MA, Passmore JC: Neutrophils and renal failure. Am J Kidney Dis 34:384-399, 1999. (Pubitemid 29362111)
3. Butcher EC: Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033-1036, 1991. (Pubitemid 121001517)
4. Singbartl K, Forlow B, Ley K: Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure. FASEB J 15: 2337-2344, 2001. (Pubitemid 33063162)
5. Choi DE, Jeong JY, Lim BJ, Na KR, Shin YT, Lee KW: Pretreatment with the tumor necrosis factor-alpha blocker etanercept attenuated ischemia-reperfusion renal injury. Transplant Proc 41(9):3590-3596, 2009.
6. Singbartl K, Green SA, Ley K: Blocking P-selectin protects from ischemia/reperfusionYinduced acute renal failure. FASEB J 14:48-54, 2000. (Pubitemid 30051522)
7. Coughlin SR: How the protease thrombin talks to cells. Proc Natl Acad Sci USA 96:11023-11027, 1999. (Pubitemid 29487321)
8. Handa O, Naito Y, Yoshikawa T: Rat cytokine-induced neutrophil chemoattractant-1 (CINC-1) in inflammation. J Clin Biochem Nutr 38:51-58, 2006.
9. Cunningham MA, Rondeau E, Chen X, Coughlin SR, Holdsworth SR, Tipping PG: Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis. J Exp Med 191:455-462, 2000.
10. Rondeau E, Vigneau C, Berrou J: Role of thrombin receptors in the kidney: lessons from PAR1 knock-out mice. Nephron Dial Transplant 16:1529-1531, 2001. (Pubitemid 32750436)
11. Grandaliano G, Monno R, Ranieri E, Gesuldo L, Schena FP, Martino C, Ursi M: Regenerative and proinflammatory effects of thrombin on human proximal tubular cells. J Am Soc Nephrol 11(6):1016-1025, 2000. (Pubitemid 30367931)
12. Gui Y, Loutzenhiser R, Hollenberg MD: Bidirectional regulation of renal hemodynamics by activation of PAR1 and PAR2 in isolated perfused rat kidney. Am J Physiol Renal Physiol 285(1):F95YF104, 2003.
13. Tsuboi H, Naito Y, Katada K, Takagi T, Hanada O, Kokura S, Ichikawa H, Yoshida N, Tsukada M, Yoshikawa T: Role of the thrombin/protease-activated receptor 1 pathway in intestinal ischemia-reperfusion injury in rats. Am J Physiol Gastrointest Liver Physiol 292(2):G678YG683, 2007.
14. Strande JL, Hsu A, Su J, Fu X, Gross GJ, Baker JE: SCH79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts. Basic Res Cardiol 102(4):350-358, 2007. (Pubitemid 46909714)
15. Sevastos J, Kennedy SE, Davis DR, Sam M, Peake PW, Charleswath JA, Mackman N, Erlich JH: Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury. Blood 109(2):577-583, 2007. (Pubitemid 46105956)
16. Ahn HS, Foster C, Boykow G, Stamford A, Manna M, Graziano M: Inhibition of cellular action of thrombin by N3-clopropyl-7-[[4-(1-methylethyl)phenyl] methyl]-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine (SCH79797), a nonpeptide thrombin receptor antagonist. Biochem Pharmacol 60(10):1425-1434, 2000.
17. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN: The protein kinase encoded by the Akt protooncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81(5):727-736, 1995.
18. Vlahos CJ, Matter WF, Hui KY, Brown RF: A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl 1-4H-1-benzopyran-4- one (LY294002). J Biol Chem 269(7);5241-5248, 1994.
19. Gueler F, Rong S, Park JK, Fiebeler A, Menne J, Egler M, Muller DN, Hampich F, Dechend R, Kunter U, et al.: Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol 13(9):2288-2298, 2002. (Pubitemid 34925239)
20. Jablonski P, Howden BO, Rae DA, Birrell CS, Marshall VC, Tange J: An experimental model for assessment of renal recovery from warm ischemia. Transplantation 35(3):198-204, 1983. (Pubitemid 13113785)
21. Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM: Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 288(2):H971YH976, 2005.
22. Joo JD, Kim M, D'Agati VD, Lee T: Ischemic preconditioning provides both acute and delayed protection against renal ischemia and reperfusion injury in mice. J Am Soc Nephrol 17(11):3115-3123, 2006. (Pubitemid 44707771)
23. Akcay A, Nguyen Q, Edelstein CL: Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009:137072, 2009.
24. Wu CC, Teng CM. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation. Eur J Pharmacol 546:142-147, 2006.
25. Nitescu N, Grimberg E, Rickesten SE, Marcussen N, Guran G: Thrombin inhibition with melargatran does not attenuate renal ischemia reperfusion injury in rats. Nephrol Dial Transplant 22(8):2149-2155, 2007. (Pubitemid 47244691)
26. Ku DD, Zaleski JK: Receptor mechanism of thrombin-induced endotheliumdependent and endothelium-independent coronary vascular effects in dogs. J Cardiovasc Pharmacol 22:609-616, 1993. (Pubitemid 23286758)
27. Naldini A, Carney DH, Pucci A, Pasquali A, Carraro F: Thrombin regulates the expression of proangiogenic cytokines via proteolytic activation of proteaseactivated receptor-1. Gen Pharmacol 35:255-259, 2000. (Pubitemid 34215118)
28. Fan Y, Zhang W, Mulholland M: Thrombin and PAR-1YAP increase proinflammatory cytokine expression in C6 cells. J Surg Res 129:196-201, 2005. (Pubitemid 41797055)
29. Coughlin SR: Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3:1800-1814, 2005. (Pubitemid 41716567)
30. Macfarlane SR, Plevin R: Intracellular signaling by the G-protein coupled protease activated receptor (PAR) family. Drug Dev Res 59:367-374, 2003. (Pubitemid 37107412)
31. Ohmori T, Yatomi Y, Asazuma N, Satoh K, Ozaki Y: Involvement of prolinerich tyrosine kinase2 in platelet activation: tyrosine phosphorylation mostly dependent on alpha IIb beta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Sch through Grb2. Biochem J 347(Pt 2): 561-569, 2000. (Pubitemid 30229405)
32. Rahman A, True AL, Anwar KN, Ye RD, Voyo-Yasenetskaya TA, Malik AB: Galpha(q) and Gbetagamma regulate PAR1 signaling of thrombin-induced NF-kappaB activation and ICAM-1 transcription in endothelial cells. Circ Res 91:398-405, 2002. (Pubitemid 35034207)
33. Oestreich J: SCH-530348, a thrombin receptor (PAR-1) antagonist for the prevention and treatment of atherothrombosis. Curr Opin Investig Drugs 10: 988-996, 2009.
34. White LE, Hassoun HT: Inflammatory mechanisms of organ crosstalk during ischemic acute kidney injury. Int J Nephrol 2012:505197, 2012.